Comparison
2p13 2 Microdeletion Syndrome C4749460 vs 16p13 11 Microdeletion Syndrome C4304596
Clinical comparison between 2p13 2 Microdeletion Syndrome and 16p13 11 Microdeletion Syndrome for differential diagnosis and treatment planning.
2p13 2 Microdeletion Syndrome C4749460
A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.
16p13 11 Microdeletion Syndrome C4304596
A rare chromosomal deletion where a portion of chromosome 16 is missing. It may be associated with developmental delays, intellectual disability, and sometimes congenital anomalies. Management focuses on supportive care and addressing individual needs.
6 comparison axes
Onset
2p13 2 Microdeletion Syndrome C4749460
0-0
16p13 11 Microdeletion Syndrome C4304596
0-null
Onset patterns differ
Severity
2p13 2 Microdeletion Syndrome C4749460
severe
16p13 11 Microdeletion Syndrome C4304596
moderate
Different severity levels
Chronic
2p13 2 Microdeletion Syndrome C4749460
Chronic
16p13 11 Microdeletion Syndrome C4304596
Chronic
Differing course
Communicable
2p13 2 Microdeletion Syndrome C4749460
No
16p13 11 Microdeletion Syndrome C4304596
No
Different transmission
Body System
2p13 2 Microdeletion Syndrome C4749460
congenital
16p13 11 Microdeletion Syndrome C4304596
congenital
Same/different system
Category
2p13 2 Microdeletion Syndrome C4749460
rare-disease
16p13 11 Microdeletion Syndrome C4304596
genetic
Different category
Bottom line
2p13-2-microdeletion-syndrome-C4749460 and 16p13-11-microdeletion-syndrome-C4304596 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2p13 2 Microdeletion Syndrome C4749460 | 16p13 11 Microdeletion Syndrome C4304596 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | Small missing segment of chromosome 2 at 2p13.2 | Missing portion of chromosome 16 at 16p13.11 | High |
| Developmental features | Features vary by affected genes; no definitive pattern is established | May include developmental delay, intellectual disability, and sometimes anomalies | Moderate |
| Severity label | Source labels the condition severe | Source labels the condition moderate | Low |
When to favor each condition
Choose 2p13 2 Microdeletion Syndrome C4749460 when
Testing shows a deletion at 2p13.2
The chromosome and band localize this diagnosis
High
Phenotype is variable without a 16p13.11 result
Symptoms alone do not establish either syndrome
Moderate
Planning care after genetic confirmation
Management should address the individual’s confirmed findings
Moderate
Choose 16p13 11 Microdeletion Syndrome C4304596 when
Testing shows a deletion at 16p13.11
The locus distinguishes it from a chromosome 2 deletion
High
Developmental delay or disability with this confirmed locus
The source associates these features, but confirmation remains essential
Moderate
Need for individualized supportive care
Management focuses on developmental and medical needs, not a fixed regimen
Moderate
How key tests differ
| Test | 2p13 2 Microdeletion Syndrome C4749460 | 16p13 11 Microdeletion Syndrome C4304596 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 2p13.2 | Deletion involving 16p13.11 | The genomic locus separates the conditions; genetics review is required. |
| Standard karyotype | May be normal if the deletion is small | May also miss a small deletion | A normal karyotype does not exclude either microdeletion. |
| Developmental assessment | No single pattern is established | Delay, disability, or anomalies may be found | Clinical overlap is possible, so assessment supports but does not replace genetic testing. |
Prognosis comparison
2p13 2 Microdeletion Syndrome C4749460
- Outcome
- Labeled severe, but individual outcome is not established.
- Factors
- Affected genes, associated findings, and available supports.
16p13 11 Microdeletion Syndrome C4304596
- Outcome
- Labeled moderate, with possible developmental disability.
- Factors
- Deletion effects, developmental profile, anomalies, and supports.
Time frame: Both are described as chronic; exact course is not established.
Genetic confirmation, clinical findings, early support, and follow-up influence care needs.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopment | Variable and not specifically defined here Delay or intellectual disability may occur Neither finding is universal; individualized evaluation is needed. |
| Congenital anomalies | Possible depending on affected genes, but unspecified Sometimes associated, according to the source Do not assume anomalies are present in every person. |
| Medical complexity | Severe label suggests potentially greater complexity Moderate label does not exclude important needs Severity labels are not established individual prognoses. |
Patient education highlights
- HighConfirmation
The diagnosis depends on which chromosomal segment is missing and should be interpreted by a clinician or geneticist.
- HighTransmission
Neither condition is communicable; the supplied transmission difference is not supported.
- MediumCare
Care is supportive and individualized. No standard dose or definitive treatment is established here.